EQUINOX NEPREMICNINE d.d. (LJSE:EQNX)
Slovenia
· Delayed Price · Currency is EUR 63.00
+3.00 (5.00%)
At close: Mar 9, 2026
EQUINOX NEPREMICNINE d.d. Revenue
In the year 2025, EQUINOX NEPREMICNINE d.d. had annual revenue of 9.37M EUR with 8.10% growth. EQUINOX NEPREMICNINE d.d. had revenue of 2.39M in the quarter ending December 31, 2025, a decrease of -2.40%.
Revenue
9.37M
Revenue Growth
+8.10%
P/S Ratio
12.00
Revenue / Employee
n/a
Employees
n/a
Market Cap
112.44M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 9.37M | 702.00K | 8.10% |
| Dec 31, 2024 | 8.67M | 884.07K | 11.35% |
| Dec 31, 2023 | 7.79M | 442.80K | 6.03% |
| Dec 31, 2022 | 7.34M | 629.52K | 9.38% |
| Dec 31, 2021 | 6.71M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| KD, financna druzba, d. d. | 23.89M |
| CETIS, Graphic and Documentation Services, d.d. | 113.62M |
| Cinkarna Celje, d. d. | 202.97M |
| Terme Catez, d.d. | 39.05M |
| SALUS, Ljubljana, d. d. | 673.54M |
| Telekom Slovenije, d.d. | 728.11M |
| UNIOR Kovaska industrija d.d. | 230.51M |
| Luka Koper d.d. | 370.18M |